Login / Signup
Half-dose ocrelizumab in selected patients with relapsing-remitting multiple sclerosis.
Hussein Algahtani
Bader Shirah
Abdulhadi Alqahtani
Nawal Abdelghaffar
Samiah Makki
Published in:
Acta neurologica Belgica (2023)
Keyphrases
</>
multiple sclerosis
white matter